vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and DYNEX CAPITAL INC (DX). Click either name above to swap in a different company.

DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $34.4M, roughly 1.3× CareCloud, Inc.). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 21.9%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 15.1%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

CCLD vs DX — Head-to-Head

Bigger by revenue
DX
DX
1.3× larger
DX
$43.5M
$34.4M
CCLD
Growing faster (revenue YoY)
DX
DX
+509.4% gap
DX
531.3%
21.9%
CCLD
Faster 2-yr revenue CAGR
DX
DX
Annualised
DX
75.8%
15.1%
CCLD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCLD
CCLD
DX
DX
Revenue
$34.4M
$43.5M
Net Profit
Gross Margin
Operating Margin
9.1%
Net Margin
Revenue YoY
21.9%
531.3%
Net Profit YoY
EPS (diluted)
$0.06
$1.59

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
DX
DX
Q4 25
$34.4M
$43.5M
Q3 25
$31.1M
$30.6M
Q2 25
$27.4M
$23.1M
Q1 25
$27.6M
$17.1M
Q4 24
$28.2M
Q3 24
$28.5M
Q2 24
$28.1M
Q1 24
$26.0M
$-3.2M
Net Profit
CCLD
CCLD
DX
DX
Q4 25
Q3 25
$3.1M
$150.4M
Q2 25
$2.9M
$-13.6M
Q1 25
$1.9M
$-3.1M
Q4 24
Q3 24
$3.1M
Q2 24
$1.7M
Q1 24
$-241.0K
$40.1M
Operating Margin
CCLD
CCLD
DX
DX
Q4 25
9.1%
Q3 25
10.3%
Q2 25
10.9%
Q1 25
7.3%
Q4 24
12.2%
Q3 24
11.4%
Q2 24
8.1%
Q1 24
0.5%
Net Margin
CCLD
CCLD
DX
DX
Q4 25
Q3 25
9.8%
491.3%
Q2 25
10.6%
-58.8%
Q1 25
7.0%
-18.0%
Q4 24
Q3 24
10.9%
Q2 24
6.0%
Q1 24
-0.9%
-1256.8%
EPS (diluted)
CCLD
CCLD
DX
DX
Q4 25
$0.06
$1.59
Q3 25
$0.04
$1.08
Q2 25
$0.04
$-0.14
Q1 25
$-0.04
$-0.06
Q4 24
$0.00
Q3 24
$-0.04
Q2 24
$-0.14
Q1 24
$-0.10
$0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
DX
DX
Cash + ST InvestmentsLiquidity on hand
$531.0M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$2.5B
Total Assets
$87.6M
$17.3B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
DX
DX
Q4 25
$531.0M
Q3 25
$491.0M
Q2 25
$387.5M
Q1 25
$327.4M
Q4 24
Q3 24
Q2 24
Q1 24
$295.7M
Total Debt
CCLD
CCLD
DX
DX
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCLD
CCLD
DX
DX
Q4 25
$59.5M
$2.5B
Q3 25
$57.8M
$2.0B
Q2 25
$56.1M
$1.6B
Q1 25
$54.2M
$1.4B
Q4 24
$49.8M
Q3 24
$46.5M
Q2 24
$43.2M
Q1 24
$41.4M
$958.5M
Total Assets
CCLD
CCLD
DX
DX
Q4 25
$87.6M
$17.3B
Q3 25
$90.6M
$14.2B
Q2 25
$75.2M
$11.3B
Q1 25
$73.6M
$9.0B
Q4 24
$71.6M
Q3 24
$70.7M
Q2 24
$74.0M
Q1 24
$76.9M
$6.3B
Debt / Equity
CCLD
CCLD
DX
DX
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
DX
DX
Operating Cash FlowLast quarter
$8.7M
$120.8M
Free Cash FlowOCF − Capex
$6.6M
FCF MarginFCF / Revenue
19.0%
Capex IntensityCapex / Revenue
6.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
DX
DX
Q4 25
$8.7M
$120.8M
Q3 25
$7.4M
$68.3M
Q2 25
$7.4M
$31.9M
Q1 25
$5.1M
$6.4M
Q4 24
$5.2M
Q3 24
$7.1M
Q2 24
$4.3M
Q1 24
$4.1M
$-17.1M
Free Cash Flow
CCLD
CCLD
DX
DX
Q4 25
$6.6M
Q3 25
$6.5M
Q2 25
$6.2M
Q1 25
$4.5M
Q4 24
$4.3M
Q3 24
$6.7M
Q2 24
$4.2M
Q1 24
$3.8M
FCF Margin
CCLD
CCLD
DX
DX
Q4 25
19.0%
Q3 25
20.9%
Q2 25
22.8%
Q1 25
16.2%
Q4 24
15.2%
Q3 24
23.6%
Q2 24
14.8%
Q1 24
14.5%
Capex Intensity
CCLD
CCLD
DX
DX
Q4 25
6.2%
Q3 25
2.8%
Q2 25
4.2%
Q1 25
2.3%
Q4 24
3.3%
Q3 24
1.2%
Q2 24
0.5%
Q1 24
1.1%
Cash Conversion
CCLD
CCLD
DX
DX
Q4 25
Q3 25
2.41×
0.45×
Q2 25
2.55×
Q1 25
2.62×
Q4 24
Q3 24
2.26×
Q2 24
2.56×
Q1 24
-0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

DX
DX

Segment breakdown not available.

Related Comparisons